2026 the Japanese Society of Medical Oncology Annual Meeting - JSMO2026 YOKOHAMA

Tickets for Sponsored Seminars

Only Medical Seminars require tickets.

• You can freely participate in other seminars without a ticket.

Tickets can be obtained either before the congress period or on the day of each seminars.

• Online registration is required to obtain a ticket.
• Only one ticket may be obtained for seminars held in the same time slot.
• The number of tickets is limited. They will be issued on a first-come, first-served basis and will no longer be available once all tickets are distributed.
• Reissuance is not possible. Please take care not to lose your ticket.
• Priority entry is given to attendees with a ticket; however, tickets become invalid together with the seminar start time.

Medical Seminar

Medical Seminar1Thursday, March 26 12:00 - 12:50English

MeS1

• Room 1(G3＋G4, Pacifico Yokohama North)
• EGFR Mutated NSCLC: Two Decades of Discovery and a Decade of Progress – Past, Present, and Future Therapeutic Horizons

• Chair:

  Tony Mok

  (Depertment of Clinical Oncology, The Chinese University of Hong Kong)

• Speaker:

  Yasushi Goto

  (Department of Thoracic Oncology, National Cancer Center Hospital )

• Co-host:

  AstraZeneca K.K.

Medical Seminar3Thursday, March 26 12:00 - 12:50English

Mes3

• Room 3(G6, Pacifico Yokohama North)
• Overcoming endocrine therapy resistance in HR+/HER2- metastatic breast cancer:Focusing on PI3K-AKT-mTOR pathway inhibition

• Chair:

  Junichiro Watanabe

  (Department of Breast Oncology, Juntendo University Graduate School of Medicine)

• Speaker:

  Yen-Shen Lu

  (National Taiwan University College of Medicine)

• Co-host:

  AstraZeneca K.K.

Medical Seminar4Thursday, March 26 12:00 - 12:50English

Mes4

• Room 4(G5, Pacifico Yokohama North)
• Updates in Targeted Therapies for AML in 2026 with a focus on Menin as a therapeutic target

• Chair:

  Yasushi Miyazaki

  (Department of Hematology, Unit for Radiation Effects on Humans, Atomic Bomb Disease Institute, Nagasaki University)

• Speaker:

  Naval G. Daver

  (The University of Texas MD Anderson Cancer Center)

• Co-host:

  Sumitomo Pharma Co.,Ltd.

Medical Seminar5Thursday, March 26 12:00 - 12:50English

Mes5

• Room 5(G8, Pacifico Yokohama North)
• Updates in clinical evidence ＆ 2026 outlook in biliary tract cancer treatment

• Chair:

  Makoto Ueno

  (Department of Gastroenterology, Kanagawa Cancer Center)

• Speaker:

  Robin Kate Kelley

  (Division of Hematology and Oncology, University of California, San Francisco)

• Co-host:

  MSD K.K.

Medical Seminar12Thursday, March 26 12:00 - 12:50

Mes12

• Room 12(G401＋G402, Pacifico Yokohama North)
• Treatment Strategies for Relapsed or Refractory Follicular Lymphoma

• Chair:

  Koji Izutsu

  (National Cancer Center Hospital, Department of Hematology)

• Speaker:

  Shigeru Kusumoto

  (Aichi Cancer Center, Department of Hematology and Cell Therapy)

• Co-host:

  CHUGAI PHARMACEUTICAL CO.,LTD.

Medical Seminar16Friday, March 27 12:05 - 12:55English

MeS16

• Room 2(G1, Pacifico Yokohama North)
• The future of precision oncology in gastric cancer

• Chair:

  Kei Muro

  (Aichi Cancer Center)

• Speaker:

  Raghav Sundar

  (Yale University School of Medicine and Yale Cancer Center)

• Co-host:

  Astellas Pharma Inc.

Medical Seminar17Friday, March 27 12:05 - 12:55English

MeS17

• Room 3(G6, Pacifico Yokohama North)
• Updates on Treatment Strategies for Advanced Breast Cancer

• Chair:

  Koji Matsumoto

  (Division of Medical Oncology, Hyogo Cancer Center)

• Speaker:

  Hope S. Rugo

  (Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center)

• Co-host:

  Gilead Sciences K.K

Medical Seminar18Friday, March 27 12:05 - 12:55English

MeS18

• Room 4(G5, Pacifico Yokohama North)

• Chair:

  Shigeru Kusumoto

  (Department of Hematology and Cell Therapy, Aichi Cancer Center)

• Speaker:

  Alexey Valeryevich Danilov

  (City of Hope National Medical Center)

• Co-host:

  Genmab KK, Medical Affairs/AbbVie GK, Medical

Medical Seminar19Friday, March 27 12:05 - 12:55English

MeS19

• Room 5(G8, Pacifico Yokohama North)
• Current and Future Status in Systemic Therapy for Hepatocellular Carcinoma - From Japanese, Korean, and Global Perspectives -

• Chair:

  Makoto Ueno

  (Department of Gastroenterology, Kanagawa Cancer Center)

• Speaker:

  Takahiro Kodama

  (Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine)

• Advances in chemotherapy for hepatocellular carcinoma: immunocomplex therapy and personalized medicine using biomarkers

• Speaker:

  Changhoon Yoo

  (Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.)

• The Evolving Landscape of Systemic Therapy for HCC

• Co-host:

  CHUGAI PHARMACEUTICAL CO.,LTD

Medical Seminar20Friday, March 27 12:05 - 12:55English

MeS20

• Room 6(G7, Pacifico Yokohama North)

• Chair:

  Koichi Goto

  (National cancer center Hospital East)

• Chair:

  Shun Lu

  (Shanghai chest Hospital Affiliated to Shanghai Jiaotong University School of Medicine) (Online)

• Discussants:

  Hibiki Udagawa

  (National cancer center Hospital East)

• Discussants:

  Tetsuro Taki

  (National cancer center Hospital East)

• Discussants:

  Meng Yang

  (China-Japan Friendship Hospital)

• Discussants:

  Huang Chen

  (China-Japan Friendship Hospital)

• Speaker:

  Hiroki Izumi

  (National cancer center Hospital East)

• Advancement of LC-SCRUM (Asia)

• Speaker:

  Haitao Wang

  (The second hospital of Tianjin Medical University)

• Progression on Molecular Diagnostics for NSCLC in 2025 - 2026

• Co-host:

  Amoy Diagnostics

Medical Seminar21Friday, March 27 12:05 - 12:55English

MeS21

• Room 7(G301＋G302, Pacifico Yokohama North)
• The Transformative Role of Amivantamab Plus Lazertinib Combination Therapy in First-Line Management of EGFR-Mutated Non–Small Cell Lung Cancer

• Chair:

  Tatsuya Yoshida

  (National Cancer Center Hospital Respiratory Medicine)

• Speaker:

  Byoung Chul Cho

  (Yonsei Cancer Center)

• Shifting the Treatment Landscape: Amivantamab from Exon 20 to Common Mutations

• Co-host:

  Johnson＆Johnson

Medical Seminar22Friday, March 27 12:05 - 12:55English

MeS22

• Room 8(G303＋G304, Pacifico Yokohama North)
• Advances in CML Treatment: Striving for Optimal Patient Outcomes

• Chair:

  Yosuke Minami

  (Department of Hematology, National Cancer Center Hospital East)

• Speaker:

  Jorge E. Cortes

  (Georgia Cancer Center)

• Co-host:

  Novartis Pharma K.K. Medical Affairs

Medical Seminar23Friday, March 27 12:05 - 12:55English

MeS23

• Room 10(G316＋G317, Pacifico Yokohama North)
• Treatment landscape of recurrent metastatic endometrial cancer

• Chair:

  Kan Yonemori

  (National Cancer Center Hospital, Department of Medical Oncology)

• Speaker:

  David Tan Shao Peng

  (National University of Singapore)

• Co-host:

  MSD K.K.

Medical Seminar27Friday, March 27 12:05 - 12:55English

MeS27

• Room 14(G404, Pacifico Yokohama North)
• Treatment strategies in advanced pancreatic cancer

• Chair:

  Masafumi Ikeda

  (Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East)

• Speaker:

  Teresa Macarulla

  (Medical Oncology Department, Hospital Clinic Barcelona, Translational Oncology in Upper Gastrointestinal Cancer Group, IDIBAPS, Barcelona, Spain)

• Co-host:

  Nihon Servier Co., Ltd.

Medical Seminar29Saturday, March 28 12:15 - 13:05English

MeS29

• Room 2(G1, Pacifico Yokohama North)
• Breakthroughs in Cervical cancer Therapy: Integrating Targeted Agents, Immunotherapy, and ADCs

• Chair:

  Kan Yonemori

  (National Cancer Center Hospital)

• Speaker:

  Jae-Weon Kim

  (Seoul National University)

• Co-host:

  Genmab KK, Medical Affairs

Medical Seminar30Saturday, March 28 12:15 - 13:05English

MeS30

• Room 3(G6, Pacifico Yokohama North)
• Global Standard in HR(+) HER2(-) Advanced Recurrent Breast Cancer

• Chair:

  Fumikata Hara

  (Breast Oncology, Aichi Cancer Center Hospital)

• Speaker:

  Erica L. Mayer

  (Dana-Farber　Cancer　Institute)

• Co-host:

  Eli Lilly Japan K.K.

Medical Seminar34Saturday, March 28 12:15 - 13:05English

MeS34

• Room 7(G301＋G302, Pacifico Yokohama North)
• A cutting-edge first-line treatment strategies for gastric cancer

• Chair:

  Eiji Oki

  (Department of Advanced Medicine and Innovative Technology, Gastrointestinal Surgery Kyushu University Hospital)

• Speaker:

  Sylvie Lorenzen

  (Department of Hematology and Oncology, Technical University of Munich, Munich, Germany)

• Co-host:

  MSD K.K.

Medical Seminar36Saturday, March 28 12:15 - 13:05English

MeS36

• Room 9(G314＋G315, Pacifico Yokohama North)
• Safety management for new treatment including ADC in HR+/HER2-mBC

• Chair:

  Takayuki Ueno

  (CANCER INSTITUTE HOSPITAL OF JFCR　Breast Oncology Center)

• Speaker:

  Hope S. Rugo

  (Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center)

• Co-host:

  Gilead Sciences K.K. Medical Affairs

Medical Seminar40Saturday, March 28 12:15 - 13:05English

MeS40

• Room 13(G403, Pacifico Yokohama North)
• HIF-2α Inhibition- A New Treatment Option for Patients with RCC and VHL disease

• Chair:

  Yuji Miura

  (Cancer Institute Hospital of JFCR　Medical oncology)

• Speaker:

  Eric Jonasch

  (Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX)

• Co-host:

  MSD K.K. Medical Affairs

Medical Seminar41Saturday, March 28 12:15 - 13:05

MeS41

• Room 14(G404, Pacifico Yokohama North)
• Business Efficiency through AI Utilization and Treatment Strategies for Driver Mutation-Positive Lung Cancer

• Chair:

  Hiroyasu Kaneda

  (Department of Clinical Oncology, Graduate School of Medicine, Osaka Metropolitan University)

• Speaker:

  確認中 確認中

  (Department of Dermatology, Kindai University)

• 確認中

• Speaker:

  Hiroki Izumi

  (Department of Thoracic Oncology, National Cancer Center Hospital East)

• Treatment strategy for ALK fusion-positive NSCLC toward long term survival

• Co-host:

  CHUGAI PHARMACEUTICAL CO., LTD.

Evening Seminar

Evening Seminar3Thursday, March 26 18:15 - 19:05English

ES3

• Room 3(G6, Pacifico Yokohama North)
• Treatment Intensification in metastatic hormone sensitive prostate cancer : Who, When and How?

• Chair:

  Takashi Kobayashi

  (Department of Urology, Kyoto University Graduate School of Medicine)

• Speaker:

  Ravindran Kanesvaran

  (National　Cancer　Center　Singapore)

• Co-host:

  Astellas Pharma Inc.

Evening Seminar4Thursday, March 26 18:15 - 19:05English

ES4

• Room 4(G5, Pacifico Yokohama North)
• Novel Therapies in MCL

• Chair:

  Maruyama Dai

  (The Cancer Institute Hospital of JFCR)

• Speaker:

  Michael Wang

  (Department of Lymphoma - Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center)

• Co-host:

  AstraZeneca K.K.

Evening Seminar15Friday, March 27 17:30 - 18:20English

ES15

• Room 1(G3＋G4, Pacifico Yokohama North)
• New treatment strategy on Endometrial cancer

• Chair:

  Mayu Yunokawa

  (Gynecologic Oncology Department,Medical Oncology Department, Cancer Institute Hospital)

• Speaker:

  Els Van Nieuwenhuysen

  (Gynecological Oncology, University Hospitals Leuven, Belgium)

• Co-host:

  AstraZeneca K.K.

Evening Seminar17Friday, March 27 17:30 - 18:20English

ES17

• Room 3(G6, Pacifico Yokohama North)
• Updated Treatment Strategies in Small Cell Lung Cancer : From Limited to Extensive Stage

• Chair:

  Toshiyuki Kozuki

  (Department of Respiratory Medicine and Allergology, Kochi Medical School, Kochi University.)

• Speaker:

  Niels Reinmuth

  (Department of Thoracic Oncology, Asklepios Lung Clinic Gauting, Munich, Germany)

• Co-host:

  AstraZeneca K.K.

Evening Seminar21Friday, March 27 17:30 - 18:20

ES21

• Room 7(G301＋G302, Pacifico Yokohama North)
• Treatment Strategies for KRAS G12C-Positive Lung Cancer～ Ensuring Patients Receive LUMAKRAS～

• Chair:

  Hiroshige Yoshioka

  (Department of Respiratory Medicine and Clinical Immunology, Dokkyo Medical University Saitama Medical Center)

• Speaker:

  Akito Hata

  (Department of Thoracic Oncology Kobe Minimally invasive Cancer Center)

• Co-host:

  Amgen K.K.

Evening Seminar22Friday, March 27 17:30 - 18:20

ES22

• Room 8(G303＋G304, Pacifico Yokohama North)
• Frontiers in personalized therapy of colorectal cancer: New breakthrough in BRAF mutations

• Chair:

  Akihito Tsuji

  (Department of Clinical Oncology Faculty of Medicine,Kagawa University)

• Speaker:

  Takayuki Yoshino

  (National Cancer Center Hospital East)

• Co-host:

  Merck Biopharma Co., Ltd

Evening Seminar24Friday, March 27 17:30 - 18:20

ES24

• Room 10(G316＋G317, Pacifico Yokohama North)
• solid tumor DIC(disseminated intravascular coagulation)：considerations from guidelines and clinical data

• Chair:

  Komatsu Yoshito

  (Department of Cancer Chemotherapy, Hokkaido University Hospital Cancer Center)

• Speaker:

  Yoshinobu Seki

  (Department of Hematology, Niigata University Medical and Dental Hospital/Niigata Cancer Center Hospital Department of Hematology, Niigata University Medical and Dental Hospital/Niigata Cancer Center Hospital)

• Listen, Clinical Oncologists! Deep Dive into the Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024.

• Speaker:

  Shin Takahashi

  (Choemotherapy Center, Sendai Kousei Hospital)

• From DIC to Chemotherapy: Clinical Significance and Potential of rTM

• Co-host:

  Asahi Kasei Pharma Corporation

Evening Seminar26Friday, March 27 17:30 - 18:20

ES26

• Room 12(G401＋G402, Pacifico Yokohama North)
• Clinical Application of Liquid Biopsy in Cancer Treatment

• Chair:

  Toru Mukohara

  (Department of Medical Oncology, National Cancer Center Hospital East)

• Speaker:

  Hiroshi Tada

  (ivision of Breast and Endocrine Surgery, Tohoku Medical and Pharmaceutical University Hospital)

• Clinical Value of Guardant360 Focusing on ESR1 in Luminal Metastatic/Recurrent Breast Cancer

• Speaker:

  Naohiro Nishida

  (Department of Clinical Oncology, School of Medicine, Tokai University)

• Liquid Biopsy–Driven, Tumor-Agnostic T-DXd Therapy: The Significance of ERBB2 Amplification Detection in the HERALD Study

• Co-host:

  Guardant Health Japan Corp

Evening Seminar27Friday, March 27 17:30 - 18:20

ES27

• Room 13(G403, Pacifico Yokohama North)
• Towards Eliminating Drug Lag and Drug Loss: Promoting Clinical Trials through Digitalization

• Chair:

  Tatsunori Shimoi

  (National Cancer Center Hospital)

• Speaker:

  Shinya Tsuruta

  (Ministry of Health, Labour and Welfare)

• National Initiatives on the Cancer Care Delivery System

• Speaker:

  Shousuke kita

  (National Cancer Center Hospital)

• Current Status of D to D Online Consultation and the CONNECT-Clinical Trials Study

• Speaker:

  Yukiko Namba

  (Juntendo University Urayasu Hospital)

• A New Model of Collaboration to "Deliver Clinical Trials": Experiences with Patient Enrollment via CONNECT Clinical Trials

• Co-host:

  Allm inc.

Morning Seminar

Morning Seminar6Friday, March 27 7:20 - 8:10

MoS6

• Room 6(G7, Pacifico Yokohama North)
• Transforming Small Cell Lung Cancer Treatment　～Therapeutic effects from Bispecific T-cell Engager～

• Chair:

  Seiji Yano

  (Department of Respiratory Medicine, Kanazawa University Graduate School of Medical Sciences)

• Speaker:

  Hiroshi Kagamu

  (Department of Respiratory Medicine, Saitama Medical University International Medical Center)

• Co-host:

  Amgen K.K.

Morning Seminar9Friday, March 27 7:20 - 8:10

MoS9

• Room 9(G314＋G315, Pacifico Yokohama North)
• Latest Updates in Breast Cancer Treatment

• Chair:

  Norikazu Masuda

  (Department of Breast Surgery, Graduate School of Medicine, Kyoto University)

• Speaker:

  Toshimi Takano

  (The Cancer Institute Hospital of JFCR　 Breast Medical Oncology Department)

• Co-host:

  Pfizer Japan Inc.

Morning Seminar15Saturday, March 28 7:20 - 8:10

Mos15

• Room 3(G6, Pacifico Yokohama North)
• Systemic Therapy for Advanced or Recurrent Thymic Carcinoma: A New Treatment Strategy by Atezolizumab

• Chair:

  Yasushi Goto

  (Department of Thoracic Oncolgy, National Cancer Center Hospital ,Tokyo, Japan)

• Speaker:

  Shukuya Takehito

  (Department of respiratory medicine, Juntendo University)

• Co-host:

  CHUGAI PHARMACEUTICAL CO., LTD.

Morning Seminar19Saturday, March 28 7:20 - 8:10English

Mos19

• Room 7(G301＋G302, Pacifico Yokohama North)
• AI-Integrated Tissue- or Liquid Biopsy Profiling (WES/WTS) in Precision Oncology

• Chair:

  Manabu Muto

  (Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University)

• Speaker:

  Hidetoshi Hayashi

  (Department of Medical Oncology, Kindai University, Faculty of Medicine)

• Speaker:

  Matthew Oberley

  (Caris Life Sciences Inc.)

• Co-host:

  Caris K.K.

Morning Seminar24Saturday, March 28 7:20 - 8:10English

Mos24

• Room 14(G404, Pacifico Yokohama North)
• Frontiers in the Clinical Application of Whole Genome Sequencing

• Chair:

  確認中 確認中

  (Graduate School of Medicine, The University of Tokyo)

• Speaker:

  Hidenori Kage

  (Graduate School of Medicine, The University of Tokyo)

• Genomic Testing in Cancer: From CDx and CGP to WGS Hidenori Kage（Department of Respiratory Medicine, Graduate School of Medicine, The University of Tokyo）

• Speaker:

  Jeong Seok Lee

  (Inocras Inc.)

• The Clinical Utility of Whole Genome Data: Impact on Breast Cancer Patients

• Co-host:

  Summit Pharmaceuticals International Corporation/ Inocras Inc.